{"id":"https://openalex.org/W2322601372","doi":"https://doi.org/10.1097/00005344-200109011-00005","title":"Beyond Remodeling: A New Paradigm for Angiotensin-Converting Enzyme Inhibitors Following Myocardial Infarction","display_name":"Beyond Remodeling: A New Paradigm for Angiotensin-Converting Enzyme Inhibitors Following Myocardial Infarction","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2322601372","doi":"https://doi.org/10.1097/00005344-200109011-00005","mag":"2322601372","pmid":"https://pubmed.ncbi.nlm.nih.gov/11392477"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-200109011-00005","doi":"https://doi.org/10.1097/00005344-200109011-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-200109011-00005","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054830306","display_name":"Scott David Solomon","orcid":"https://orcid.org/0000-0003-3698-9597","observed_orcids":["https://orcid.org/0000-0003-3698-9597"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott D Solomon","raw_affiliation_strings":["Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 02115, USA","Director, Noninvasive Cardiology, Brigham and Women's Hospital, Assistant Professor of Medicine, Harvard Medical School, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Director, Noninvasive Cardiology, Brigham and Women's Hospital, Assistant Professor of Medicine, Harvard Medical School, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5054830306"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":0.7311,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.7726996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":null,"first_page":"S31","last_page":"S34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6273999810218811,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6273999810218811,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.19140000641345978,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.059300001710653305,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9940000176429749},{"id":"https://openalex.org/keywords/left-ventricular-dysfunction","display_name":"left ventricular dysfunction","score":0.9330000281333923},{"id":"https://openalex.org/keywords/ventricular-remodeling","display_name":"ventricular remodeling","score":0.9419999718666077},{"id":"https://openalex.org/keywords/anti-ischemic-effect","display_name":"anti-ischemic effect","score":0.8560000061988831},{"id":"https://openalex.org/keywords/anti-atherosclerotic-effects","display_name":"anti-atherosclerotic effects","score":0.972000002861023},{"id":"https://openalex.org/keywords/ischemic-protection","display_name":"ischemic protection","score":0.5830000042915344},{"id":"https://openalex.org/keywords/mortality-reduction","display_name":"mortality reduction","score":0.453000009059906},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.8122504353523254},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.778860330581665},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7635903358459473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.69660484790802},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6964099407196045},{"id":"https://openalex.org/C2779537366","wikidata":"https://www.wikidata.org/wiki/Q7920323","display_name":"Ventricular remodeling","level":3,"score":0.69203782081604},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.6379916667938232},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.5054912567138672},{"id":"https://openalex.org/C2777798775","wikidata":"https://www.wikidata.org/wiki/Q207550","display_name":"Infarction","level":3,"score":0.4282560646533966},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.08640739321708679}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D020257","descriptor_name":"Ventricular Remodeling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020257","descriptor_name":"Ventricular Remodeling","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-200109011-00005","doi":"https://doi.org/10.1097/00005344-200109011-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-200109011-00005","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:11392477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11392477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W297892089","https://openalex.org/W1690120260","https://openalex.org/W1964193968","https://openalex.org/W1968355808","https://openalex.org/W1970442360","https://openalex.org/W1977884590","https://openalex.org/W1980000060","https://openalex.org/W1981594756","https://openalex.org/W1988569489","https://openalex.org/W1990224341","https://openalex.org/W1991977300","https://openalex.org/W2003563752","https://openalex.org/W2004114486","https://openalex.org/W2028455468","https://openalex.org/W2050177211","https://openalex.org/W2069445171","https://openalex.org/W2076066102","https://openalex.org/W2076907458","https://openalex.org/W2078757161","https://openalex.org/W2312388685","https://openalex.org/W2326354230","https://openalex.org/W2333508981","https://openalex.org/W2340149484","https://openalex.org/W2617392052","https://openalex.org/W2747176423","https://openalex.org/W2895806954","https://openalex.org/W4321429281"],"related_works":["https://openalex.org/W2171772550","https://openalex.org/W2160191533","https://openalex.org/W1978175606","https://openalex.org/W7035770313","https://openalex.org/W2064099037","https://openalex.org/W2084573540","https://openalex.org/W4300868197","https://openalex.org/W1984247538","https://openalex.org/W2411459501","https://openalex.org/W2152044516"],"abstract_inverted_index":{"Angiotensin":[0],"converting":[1],"enzyme":[2],"(ACE)":[3],"inhibitors,":[4],"originally":[5],"designed":[6],"to":[7,13,19,28,42],"treat":[8],"hypertension,":[9],"were":[10,40],"quickly":[11],"demonstrated":[12],"confer":[14,96],"hemodynamic":[15],"and":[16,46,85],"survival":[17],"benefit":[18],"patients":[20,29],"with":[21,30],"congestive":[22],"heart":[23],"failure.":[24],"Extending":[25],"this":[26],"paradigm":[27],"left":[31],"ventricular":[32,44],"dysfunction":[33],"(LVD)":[34],"post-myocardial":[35],"infarction":[36],"(MI),":[37],"ACE":[38,53,80,94],"inhibitors":[39,54,81,95],"shown":[41,92],"attenuate":[43],"remodeling":[45],"reduce":[47,56],"mortality.":[48],"An":[49],"unexpected":[50],"finding":[51],"that":[52,79,93],"could":[55],"the":[57,77],"incidence":[58],"of":[59,73],"myocardial":[60],"infarction,":[61],"prompted":[62],"enormous":[63],"interest":[64],"in":[65],"their":[66],"anti-ischemic":[67,86],"potential.":[68],"Indeed,":[69],"a":[70],"significant":[71,97],"body":[72],"experimental":[74],"literature":[75],"supports":[76],"concept":[78],"have":[82,91],"direct":[83],"anti-atherosclerotic":[84],"effect.":[87],"Recent":[88],"clinical":[89],"trials":[90],"protection":[98],"from":[99],"ischemic":[100],"events.":[101]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}